Home › Therapeutic areas › Ophthalmology › Inherited Retinal Disease
Inherited Retinal Disease (5 companies)
Companies with an active program in Inherited Retinal Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| KPRX | Kiora Pharmaceuticals | Ophthalmology Rare | 1 | Phase 3 | $6.4M | 4 |
| LCTX | Lineage Cell Therapeutics | MetabolicNeurology+1 Rare | 1 | Phase 2 | $258M | 12 |
| MGTX | MeiraGTx | ImmunologyMetabolic+2 Rare | 2 | Phase 3 | $864M | 16 |
| OCGN | Ocugen | Infectious DiseaseOphthalmology Rare | 2 | Phase 3 | $314M | 12 |
| IRD | Opus Genetics | Ophthalmology Rare | 6 | Approved | $348M | 12 |
No companies match.